RT Journal Article
SR Electronic
T1 957 The ATR-inhibitor ceralasertib modulates the tumor microenvironment and improves the effect of anti-PDL1 by activating type I IFN pathway
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1064
OP A1064
DO 10.1136/jitc-2023-SITC2023.0957
VO 11
IS Suppl 1
A1 Sanseviero, Emilio
A1 Taylor, Devon
A1 Tohumeken, Sehmus
A1 Mai, Mimi
A1 Mostafa, Ali
A1 Milo, Marta
A1 Mulgrew, Kathy
A1 Barry, Simon
A1 Fuchs, Serge
A1 Cobbold, Mark
A1 Gabrilovich, Dmitry
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1064.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.